Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gerald Bryan Pier, Ph.D.

Co-Author

This page shows the publications co-authored by Gerald Pier and Donald Goldmann.
Connection Strength

1.654
  1. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev. 1993 Apr; 6(2):176-92.
    View in: PubMed
    Score: 0.133
  2. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 2010 Sep; 120(9):3220-33.
    View in: PubMed
    Score: 0.111
  3. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007 Jul; 75(7):3406-13.
    View in: PubMed
    Score: 0.088
  4. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7528-33.
    View in: PubMed
    Score: 0.088
  5. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 2006 May; 74(5):2742-50.
    View in: PubMed
    Score: 0.083
  6. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine. J Infect Dis. 2005 Dec 01; 192(11):2012-9.
    View in: PubMed
    Score: 0.080
  7. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005 Oct; 73(10):6752-62.
    View in: PubMed
    Score: 0.079
  8. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun. 2005 Oct; 73(10):6868-76.
    View in: PubMed
    Score: 0.079
  9. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2005 Jun; 49(6):2467-73.
    View in: PubMed
    Score: 0.077
  10. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol. 2004 Apr; 186(8):2449-56.
    View in: PubMed
    Score: 0.071
  11. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 2004 Feb 17; 22(7):872-9.
    View in: PubMed
    Score: 0.071
  12. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun. 2002 Aug; 70(8):4433-40.
    View in: PubMed
    Score: 0.064
  13. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 2000 Sep 29; 83(1-2):37-44.
    View in: PubMed
    Score: 0.056
  14. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000 Aug; 68(8):4631-6.
    View in: PubMed
    Score: 0.055
  15. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999 May 28; 284(5419):1523-7.
    View in: PubMed
    Score: 0.051
  16. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun. 1999 Mar; 67(3):1213-9.
    View in: PubMed
    Score: 0.050
  17. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 1998 Oct; 66(10):4711-20.
    View in: PubMed
    Score: 0.049
  18. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 1995 Nov 01; 92(9):2715-22.
    View in: PubMed
    Score: 0.040
  19. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis. 1995 Jan; 171(1):220-4.
    View in: PubMed
    Score: 0.038
  20. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis. 1994 May; 169(5):1042-9.
    View in: PubMed
    Score: 0.036
  21. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis. 1994 Mar; 169(3):526-31.
    View in: PubMed
    Score: 0.036
  22. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis. 1993 Nov; 168(5):1211-8.
    View in: PubMed
    Score: 0.035
  23. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 Feb; 61(2):551-8.
    View in: PubMed
    Score: 0.033
  24. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 1991 Dec; 84(6):2539-46.
    View in: PubMed
    Score: 0.030
  25. Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun. 1991 Sep; 59(9):3323-6.
    View in: PubMed
    Score: 0.030
  26. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 1990 Aug; 162(2):435-41.
    View in: PubMed
    Score: 0.028
  27. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol. 2008 May; 43(5):463-71.
    View in: PubMed
    Score: 0.024
  28. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988 Apr; 157(4):713-22.
    View in: PubMed
    Score: 0.024
  29. Mucoid Escherichia coli in cystic fibrosis. N Engl J Med. 1981 Jun 11; 304(24):1445-9.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.